Quality of Life in Patients with Acute Severe Ulcerative Colitis: Long-Term Follow-Up Results from the CONSTRUCT Trial.

Laith Alrubaiy Hayley Anne HutchingsAndrea LoucaFrances RapportAlan WatkinsShaji SebastianJohn G Williams

Published in: Journal of personalized medicine (2022)

Both infliximab and ciclosporin improve QoL following initial treatment for ASUC. QoL scores remain higher than at admission up to 84 months post-treatment.

Keyphrases

ulcerative colitis
emergency department
clinical trial
randomized controlled trial
study protocol
early onset
combination therapy
phase ii